Clinical trials
Hypoglycemia trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
90 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 4 |
| 2014 | 2 |
| 2015 | 7 |
| 2016 | 6 |
| 2017 | 7 |
| 2018 | 4 |
| 2019 | 8 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 7 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
| Recruiting | 10 |
| Terminated | 10 |
| Withdrawn | 6 |
| Unknown status | 3 |
| Suspended | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brigham and Women's Hospital | 6 |
| Joslin Diabetes Center | 5 |
| Kaiser Permanente | 4 |
| University of Virginia | 4 |
| Yale University | 4 |
| Indiana University | 3 |
| Jaeb Center for Health Research | 3 |
| Johns Hopkins University | 3 |
| Oregon Health and Science University | 3 |
| University of Pennsylvania | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypoglycemia | 90 |
| Diabetes Mellitus, Type 1 | 36 |
| Diabetes Mellitus | 28 |
| Hyperglycemia | 22 |
| Diabetes Mellitus, Type 2 | 13 |
| Insulin Resistance | 8 |
| Critical Illness | 3 |
| Dementia | 2 |
| Pain | 2 |
| Adenoma, Islet Cell | 1 |
Trials
Showing 1 to 25 of 90. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.